4.7 Article

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes

Journal

DIABETES
Volume 67, Issue 7, Pages 1414-1427

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db17-0914

Keywords

-

Funding

  1. European Union's Seventh Framework Program (FP7) for the Innovative Medicine Initiative [IMI/115006]
  2. Academy of Finland [263401, 267882]
  3. Association Diabete Risque Vasculaire in Paris
  4. Agency for Science, Technology and Research (A* STAR) in Singapore
  5. Albert Pahlsson Foundation
  6. Diabetesfonden
  7. Alexandra Health [SIGII/08005, SIGII/11001, SIG/11029, SIG/12024, SIG II/15205]
  8. Chinese University of Hong Kong Focused Investment Scheme
  9. Danish Diabetes Academy
  10. DOLOrisk (European Union's Horizon research and innovation program) [633491]
  11. European Research Council [269045-GENE TARGET T2D, 649021]
  12. Ernhold Lundstrom
  13. Finska Lakaresallskapet
  14. Folkhalsan Research Foundation
  15. French Ministry of Health
  16. Heart Foundation of Jakobstad region
  17. Helsinki University Central Hospital Research Funds
  18. Hong Kong Food and Health Bureau [01120796]
  19. Hong Kong Foundation for Research and Development in Diabetes
  20. Hong Kong Government Research Grant Committee and Innovation and Technology Grant Committee
  21. Hong Kong Research Grants Council Theme-based Research Scheme [T12-402/13N]
  22. Japan Agency for Medical Research and Development
  23. JDRF [17-2012-542, 17-2013-7, 2-SRA-2014-276-Q-R, 17-2013-9]
  24. Knut and Alice Wallenberg Foundation
  25. Leading Project of Ministry of Education, Culture, Sports, Science and Technology in Japan
  26. Liao Wun Yuk Memorial Fund
  27. Linneus Foundation for the Lund University Diabetes Center
  28. Liv och Halsa Foundation
  29. Ministry of Education, Culture, Sports, Science and Technology of the Japanese government
  30. National Institute for Health Research Cambridge Biomedical Research Centre
  31. National Medical Research Council in Singapore [CIRG13nov045]
  32. Natural Sciences and Engineering Research Council of Canada
  33. National Health Services Tayside
  34. National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK105154]
  35. National Institutes for Health [R01-MH101814]
  36. Novo Nordisk Foundation [NNF14SA0003, NNF15CC0018486]
  37. Pahlsson Foundation
  38. Region Skane
  39. Rhodes Trust
  40. Signe and Ane Gyllenberg Foundation
  41. Sigrid Juselius Foundation
  42. Skane University Hospital
  43. Societe Francophone du Diabete
  44. Swedish Diabetes Foundation
  45. Swedish Heart and Lung Foundation
  46. Swedish Research Council
  47. Turku University Hospital Research Funds
  48. University of Dundee
  49. Vasa Hospital District
  50. Wellcome [072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, 085475/B/08/Z, 098381, 090532, 106310]
  51. Wilhelm and Else Stockmann Foundation
  52. Wellcome Trust [085475/Z/08/Z, 084726/Z/08/Z, 085475/B/08/Z] Funding Source: Wellcome Trust
  53. MRC [MC_PC_15025] Funding Source: UKRI

Ask authors/readers for more resources

Identification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential to provide insights into the pathophysiological mechanisms responsible. We conducted a genome-wide association study (GWAS) of DKD in type 2 diabetes (T2D) using eight complementary dichotomous and quantitative DKD phenotypes: the principal dichotomous analysis involved 5,717 T2D subjects, 3,345 with DKD. Promising association signals were evaluated in up to 26,827 subjects with T2D (12,710 with DKD). A combined T1D+T2D GWAS was performed using complementary data available for subjects with T1D, which, with replication samples, involved up to 40,340 subjects with diabetes (18,582 with DKD). Analysis of specific DKD phenotypes identified a novel signal near GABRR1 (rs9942471, P = 4.5 x 10(-8)) associated with microalbuminuria in European T2D case subjects. However, no replication of this signal was observed in Asian subjects with T2D or in the equivalent T1D analysis. There was only limited support, in this substantially enlarged analysis, for association at previously reported DKD signals, except for those at UMOD and PRKAG2, both associated with estimated glomerular filtration rate. We conclude that, despite challenges in addressing phenotypic heterogeneity, access to increased sample sizes will continue to provide more robust inference regarding risk variant discovery for DKD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available